Metabolic Dysfunction-Associated Steatotic Liver Disease and PeripheralArterial Disease: Associations and Treatment Considerations

MASLD and PAD frequently coexist. Targeting both conditions is expected to reduce the elevated cardiovascular risk observed in patients affected by both MASLD and PAD.

Authors

Institutions

Publication Details

Journal
Current Vascular Pharmacology
Published
2026-01-15
DOI
https://doi.org/10.2174/0115701611414052251127074106
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Dysfunction-Associated Steatotic Liver Disease and PeripheralArterial Disease: Associations and Treatment Considerations

Antonis Goulas, Myrsini Orfanidou, Stergios A. Polyzos, Jannis Kountouras
Current Vascular Pharmacology
Liver Disease Diagnosis and Treatment
article

Metabolic Dysfunction-Associated Steatotic Liver Disease and PeripheralArterial Disease: Associations and Treatment Considerations

Antonis Goulas, Myrsini Orfanidou, Stergios A. Polyzos, Jannis Kountouras
article en

Abstract

MASLD and PAD frequently coexist. Targeting both conditions is expected to reduce the elevated cardiovascular risk observed in patients affected by both MASLD and PAD.

Current Vascular PharmacologyVol. 24
Aristotle University of Thessaloniki (GR)
Good health and well-being
Openalex Percentile: Top 78%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metabolic Dysfunction-Associated Steatotic Liver Disease and PeripheralArterial Disease: Associations and Treatment Considerations — Antonis Goulas, Myrsini Orfanidou, et al. · Current Vascular Pharmacology (2026) | TGRS Research Map | TGRS